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The gastrointestinal tract is a passageway for dietary nutrients, microorganisms and xenobiotics.
The gut is home to diverse bacterial communities forming the microbiota. While bacteria and their
metabolites maintain gut homeostasis, the host uses innate and adaptive immune mechanisms to
cope with the microbiota and luminal environment. In recent years, multiple bi-directional instruc-
tive mechanisms between microbiota, luminal content and mucosal immune systems have been
uncovered. Indeed, epithelial and immune cell-derived mucosal signals shape microbiota composi-
tion, while microbiota and their by-products shape the mucosal immune system. Genetic and envi-
ronmental perturbations alter gut mucosal responses which impact onmicrobial ecology structures.
On the other hand, changes in microbiota alter intestinal mucosal responses. In this review, we dis-
cuss how intestinal epithelial Paneth and goblet cells interact with the microbiota, how environ-
mental and genetic disorders are sensed by endoplasmic reticulum stress and autophagy
responses, how speciﬁc bacteria, bacterial- and diet-derived products determine the function and
activation of the mucosal immune system. We will also discuss the critical role of HDAC activity
as a regulator of immune and epithelial cell homeostatic responses.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The gastrointestinal tract is a passageway for environment-de-
rived products including dietary nutrients, external antigens,
microorganisms and xenobiotics. The gut is home to diverse and
abundant bacterial communities forming the microbiota. Indigest-
ible-nutrient metabolism by resident enzyme-producing bacteria
supply the host with numerous metabolites required for intestinal
epithelial and immunologic maturation. Indeed, germ-free (GF)
mice display maturation defects of both mucosal epithelial and
lymphoid-associated development. In addition, bacteria and their
by-products protect against pathogen invasion and maintain gut
homeostasis. Likewise, the host uses a number of innate and adap-
tive immune mechanisms to cope with the intestinal microbiota
and luminal environment, and to safeguard host-microbiota mutu-
alism [1]. Both innate and adaptive immune cells populate the
intestinal mucosal immune system. Innate immune cells include
intestinal epithelial cells (IEC), neutrophils, dendritic cells, macro-
phages and innate lymphoid cells (ILCs). Intestinal mucosal adap-
tive cells include T-regulatory cells (T-reg) and Th17 cells. Bysecreting anti-inﬂammatory cytokines such as IL-10 and TGF-b,
T-reg cells suppress abnormal immune responses and are thus
important for gut tolerance. Th17 cells, while crucial to host de-
fense against infection, may become pathogenic as a result of aber-
rant regulatory mechanisms, as those observed during intestinal
inﬂammation. In recent years, multiple bi-directional instructive
mechanisms between microbiota, luminal content as well as
mucosal innate and adaptive immune systems have been uncov-
ered. Indeed, epithelial or immune cell-derived mucosal signals
shape microbiota composition, while the microbiota and its by-
products shape the mucosal immune system. Genetic as well as
environmental perturbations lead to defects in gut mucosal cell re-
sponses which impact on microbial ecology structures, causing
dysbiosis. On the other hand, changes in microbiota alter intestinal
mucosal cell responses. In this review, we will discuss selected
examples showing (1) how the intestinal epithelium forms the
microbiome and controls gut microbial ecology, (2) how environ-
mental and genetic perturbations are sensed through endoplasmic
reticulum (ER) stress and autophagy responses in IECs, (3) how
homeostatic responses are challenged in response to stress, and
(4) how speciﬁc bacteria, bacterial- and diet-derived products
determine the function and activation of the mucosal immune sys-
tem. We will also discuss the intriguing possibility that regulation
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for establishing immune-suppressive responses through T-reg cell
activation, but also for controlling IEC homeostatic responses to
the luminal environment.
2. The intestinal epithelium serves as a physical and biochemical
protective barrier
The mono-layered intestinal epithelium is central to intestinal
homeostasis – not only by way of its position between luminal
microbiota and the mucosal immune system, but also by its capac-
ity to sense and to respond to their respective signals (Fig. 1) [2,3].
Continuous IEC renewal is sustained by crypt stem cells whose dif-
ferentiation and maintenance are regulated by different pathways
[4]. Crypt stem cells generate multiple IEC lineages with distinct
functions, including absorptive enterocytes, mucin-producing gob-
let cells, enteroendocrine cells and antimicrobial peptide (AMP)-
secreting Paneth cells. The intestinal epithelium senses bacterial
products through innate immune receptors such as Toll-like recep-
tors and Nod-like receptors. This leads to activation of signalling
pathways regulating IEC migration and tissue repair, among others
[3]. The intestinal epithelium forms a protective physical barrier by
establishing a web of tight junctions regulating intestinal perme-
ability. Barrier function is defective in Inﬂammatory Bowel Disease
(IBD) patients, and experimental colitis models involve innate re-
sponse defects [5]. For example, TLR5-deﬁcient mice display spon-
taneous intestinal inﬂammation that may be caused by a decreased
ability to clear bacteria [6].
The intestinal epithelium also provides a chemical protective
barrier which keeps microbes at bay and inﬂuences microbiota dis-
tribution and content. Two secretory IEC lineages, namely goblet
and Paneth cells, are critical for this function. Goblet cells form a
physical and chemical defense barrier by producing transmem-
brane mucin glycoproteins and by secreting mucins – notably
Muc2 – covering the intestinal epithelium and forming a two-
tiered inner and outer layer to prevent bacterial adhesion to the
epithelium (Fig. 1). Goblet cells also express AMPs sequestered in
the mucinous gel [7,8]. While the inner dense mucous layer re-
stricts bacterial penetration and growth, the extended outer layer
forms a well-suited environment for resident bacteria [9]. The
importance of mucous protection in gut homeostasis is demon-
strated by the development of spontaneous colitis in Muc2-deﬁ-
cient mice [10], and by reduced goblet cell numbers and
depleted mucous secretion in IBD patients [11]. In addition, glycos-
ylated mucin proteins are metabolized by specialized mucous-
degrading enzyme-producing bacteria. Released oligosaccharides
are used as a food source for growth of speciﬁc bacterial subsets
– notably Bacteroides fragilis and Akkermansia muciniphila, among
others. Thus, host mucin levels could impact the abundance and
distribution of deﬁned intestinal bacterial subsets [12].
A novel role for Muc2 as a direct signalling intermediate, con-
trolling dendritic cell (DC) immunoregulation and small intestinal
tolerance, has recently been uncovered [13]. Intestinal mucosal
DCs display luminal bacterial antigens to gut immune cells [14].
LPS-induced DCs treated with glycosylated Muc2 show reduced
expression of inﬂammatory cytokines. In contrast, Muc2 treatment
induces the expression of anti-inﬂammatory and tolerogenic cyto-
kines IL-10 and TGFb, as well as retinaldehyde dehydrogenase ALD-
H1A1, which converts vitamin A into the T-reg inducer retinoic
acid. Muc2-deﬁcient IECs express decreased IL-10 and ALDH1A1
levels independently of the presence of bacteria. Gavage of Muc2
in Muc2-deﬁcient mice results in increased expression of IL-10
and ALDH1A1, among others, correlating with increased T-reg cell
numbers as well as decreased Th17 cell numbers. Interestingly,
Muc2 administration reduces dextran sulphate sodium (DSS)-
induced colitis symptoms in Muc2-deﬁcient mice. GlycosylatedMuc2-dependent signalling on DCs involves the formation of a
galectin 3-Dectin1-FccRIIB receptor whose activation leads to b-
catenin-dependent inhibition of inﬂammatory NF-jB inﬂamma-
tory signals. Thus, in addition to its role as a protective epithelial
barrier from bacterial adhesion and luminal antigens, and as a food
source for speciﬁc bacteria, Muc2 may serve as a signalling mole-
cule directly favouring DC tolerogenic – as opposed to inﬂamma-
tory – responses, or indirectly through IEC-speciﬁc modulation of
DC regulators (Fig. 1).
The small intestine’s secretory Paneth cells are juxtaposed to
intestinal epithelial stem cells in the crypt. The former are long-
lived cells that secrete stem cell-supporting factors, establishing
the stem cell niche [15], and transmit diet-related changes – such
as caloric restriction – to modulate stem cell function [16]. Paneth
cells secrete a trove of AMPs, including a-defensins and Reg lectins,
which protect against pathogens and regulate microbiota composi-
tion (Fig. 1) [17,18]. Indeed, constitutively expressed defensins reg-
ulate global bacterial communities [19]. For example, expression of
the human defensin DEFA5 gene in murine Paneth cells leads to
changes in microbiota composition – notably reduction of seg-
mented ﬁlamentous bacteria (SFB) – without affecting microbial
loads. This results in mucosal immune cell modiﬁcations, including
a decrease in IL-17-expressing T cells [19]. The Reg3g antibacterial
C-type lectin – expressed by most IEC lineages – kills Gram-posi-
tive bacteria by binding bacterial peptidoglycan and forming an
oligomeric membrane-invading pore [20,21]. Reg3g expression de-
pends on IEC Myd88-TLR signalling, as mice deﬁcient in Myd88 – a
common adapter in TLR signalling pathways – display reduced
Reg3g expression and increased bacterial interaction with the epi-
thelium. Reg3g-deﬁcient mice show increased bacteria-epithelium
association and basal mucosal inﬂammatory responses. Thus,
Reg3g is considered a regulator of surface-associated bacterial con-
tent [22,23]. Recent data have suggested an interaction between
intestinal intraepithelial lymphocytes (IELs) and Paneth cells. IELs
are specialized T immune cells in close contact with mucosal IECs.
In response to bacteria and regulatory immune cells, IELs produce
numerous cytokines which regulate mucosal barrier properties,
among others [24]. While mice lacking intestinal IELs show re-
duced levels of Ang4 – an AMP produced by Paneth cells – the
transfer of wild-type IELs to such mutant mice restores Ang4
expression. This IEL–IEC bi-directional interaction may involve
signalling ﬁrst from IECs to IELs, through IEC IL-23-dependent
stimulation of IELs, and second from IELs to IECs, through IEL
IL-22-speciﬁc activation of Ang4 in Paneth cells. This IEL–IEC inter-
action could be an important regulator of intestinal homeostasis in
the wake of bacterial challenges [25].
3. ER stress and autophagy are internal intestinal epithelial cell
sensors of environmental perturbations
The intestinal epithelium is constantly exposed to luminal sub-
stances including microbes and diet – as well as bacterial-derived
products. Paneth and goblet cells, by their extensive synthesis of
secretory products – requiring high metabolic energy levels –
and by their exquisite protein folding capabilities, are very
sensitive to environmental changes and stresses. Genome-wide
association studies have identiﬁed genetic variants with enhanced
risk of IBD, such as Crohn’s disease (CD) and ulcerative colitis (UC).
Of the numerous pathways identiﬁed, three major interacting
pathways, namely innate signalling through NOD proteins, autoph-
agy and ER stress responses, are integral to disturbed homeostatic
intestinal responses associated with Paneth and goblet cell defects
(Fig. 2) [26,27]. Nod2 is a cytosolic innate Nod-like receptor that
binds bacterial muramyl dipeptide, leading to the activation of
the pro-inﬂammatory transcription factor NF-jB [28]. Nod2 is a
susceptibility locus for CD, an IBD disease associated with defective
Fig. 1. Protective functions of Paneth and goblet cells. Intestinal epithelial cells (IEC) include specialised secretory cells involved in the establishment of a mucosal barrier to
luminal gut contents. In addition to antimicrobial proteins (AMPs), goblet cells produce transmembrane as well as secreted mucins, notably MUC2, which form a bilayered
outer and inner barrier protecting from bacterial colonization and concentrating AMPs. Mucins serve also as a host-derived food source for specialized mucin-degrading
bacteria, such as Bacteroides fragilis and Akkermansia muciniphila. Finally, MUC2 plays a direct immunoregulatory role as a signal transducer inducing the formation of IL-10-,
TGF-b-, and retinoic acid-producing tolerogenic dendritic cells, leading to T-reg cell production, and actively suppressing inﬂammatory dendritic cell responses. MUC2 forms
a receptor complex with galectin3, dectin-1 and FccRIIB that activates b-catenin, which, by interacting with NF-jB, represses inﬂammatory gene expression. In addition to
producing niche signals for crypt stem cells, small-intestine Paneth cells secrete AMPs which protect against pathogens and shape the microbiome, by controlling microbiota
composition and restricting bacterial colonization in regard to the epithelium. Overexpression of human a-defensin 5 (Defa5) in mice leads to changes in microbiota
composition, including reduced colonization by segmented ﬁlamentous bacteria. The antibacterial protein Reg3g regulates epithelial surface-associated Gram-positive
bacteria content. A reciprocal interaction between Paneth cells and intraepithelial lymphocytes (IELs) may regulate intestinal homeostasis after bacterial challenges.
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bacterial-adhesion defects of the intestinal epithelium as well as
dysbiosis. Nod2 is expressed in many mucosal cell types, including
Paneth cells. Nod2-deﬁcient mice display decreased Paneth cell a-
defensin expression [29], modiﬁed microbiota [30] and defective
pathogen-dependent immune responses [31], as well as increased
sensitivity to chemically-induced experimental colitis [32]. CDpatients with NOD2 variants express low Paneth cell a-defensin
levels – independently of inﬂammation grade – which correlate
with reduced antibacterial activity [33].
Genome-wide association studies have also identiﬁed interac-
tions between autophagy-regulating gene variants and secretory
cell perturbations. Autophagy allows cells to eliminate and recycle
misfolded proteins and impaired organelles [34]. Autophagy is
Fig. 2. ER stress and autophagy are internal intestinal epithelial cell sensors of environmental perturbations. Interactions between innate signalling, autophagy and ER stress
responses are critical for the regulation of secretory IECs, notably Paneth and goblet cells. Mutations of innate signalling receptors (NOD2), autophagy (ATG16L1) and UPR
(XBP1) genes may lead to impaired regulation of bacterial clearance, mucin and antimicrobial protein (AMP) secretion, Paneth and goblet cell function as well as stem cell
growth and differentiation potential, among others. Alterations in these pathways may compel IECs to turn into sources of inﬂammatory signals perpetuating inﬂammation.
As well, changes in the luminal environment through diet or dysbiosis may impact on the genetically-modulated mucosal stress responses.
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mitochondria or endoplasmic reticulum. Autophagy gene variants
associated with IBD have been implicated in defective intestinal
homeostasis through secretory-cell disruption. Indeed, CD patients
with ATG16L1 variants and Atg16l1 under-expressing mice display
secretory and inﬂammatory gene defects in Paneth cells [35].
Atg16l1 is required for autophagosome assembly and antibacterial
autophagy. Intriguingly, speciﬁc norovirus infection of Atg16l1
hypomorphic mice reveals altered CD-like inﬂammatory responses
after DSS-induced intestinal injury, suggesting that environmental
changes may result in the expression of gene-variant speciﬁc phe-
notypes [36]. It has been shown that the ATG16l1 protein – by
interacting with the Nod2 innate sensor – is targeted to the plasma
membrane, leading to autophagosome formation at the site of bac-
terial invasion and autophagic elimination of invading bacteria.
CD-derived Nod2 mutants are ineffective at recruiting ATG16L1
to the membrane and at bacterial removal [37]. While Salmonellatyphimurium enteric infection leads to increased autophagy in
wild-type mice, Atg16l1 IEC-speciﬁc mutant mice display abnormal
S. typhimurium autophagy, decreased induction of AMPs – notably
Reg3g and lysozyme – and diminished numbers of Paneth cells
with abnormal secretory granules. IEC-speciﬁc deﬁcient mice are
more susceptible to S. typhimurium infection, with increased
inﬂammatory chemokine expression and bacterial translocation
to spleen. Thus, autophagy and autophagy genes are critical for in-
nate immunity against bacteria. Atg16l1 is not only critical for Pa-
neth cell differentiation, but also essential for bacterial elimination
and prevention of bacterial dissemination [38]. Similar dysfunction
is observed in Atg5 IEC-speciﬁc deﬁcient mice after Shigella infec-
tion. Indeed, while ileal Shigella infection is rapidly cleared by
autophagy in wild-type mice – without signs of inﬂammation –
infection of Atg5 mutant mice results in increased cell death,
mucus secretion and bacterial invasion, as well as Paneth cell
hypertrophy. Of note, increased inﬂammatory cytokine expression
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and rapid autophagy induction may result in controlled IEC sur-
vival and inﬂammatory responses, by diminishing stress responses
leading to inﬂammation. Autophagy dysfunction may thus reduce
these initial controlled responses to bacteria, leading to increased
inﬂammatory responses and mucosal defects [39]. Other autoph-
agy genes – such as the IRGM gene – are associated with genetic
susceptibility to IBD. Recent data have revealed a role for Irgm in
intestinal homeostasis – as Irgm-deﬁcient mice display altered Pa-
neth cell localization and granule defects – correlating with dis-
rupted IEC autophagy and increased sensitivity to DSS-induced
colitis [40].
Recent data have revealed autophagy-independent functions
for autophagy proteins. For example, IEC-speciﬁc Atg16l1 silencing
increases Nod-dependent cytokine production, and autophagy-im-
paired ATG16L1 proteins drive Nod-induced cytokine responses
[41]. Thus, autophagy and bacterial clearance pathways are inti-
mately linked to direct inﬂammatory responses. Independently of
their autophagy function, autophagy proteins act as suppressors
of inﬂammatory responses. In addition, mucin secretion requires
autophagy proteins. Indeed, IEC-speciﬁc deﬁcient mice for the
autophagy gene Atg5 show increased IEC mucin accumulation.
IEC organoid culture experiments show that fusion of autophago-
somes and endosomes – with associated formation of reactive oxy-
gen species by NADPH oxidases – is critical for the regulation of
granule mucin accumulation in colonic goblet cells [42]. Thus,
autophagy proteins are not only linked to direct inﬂammatory sig-
nalling and Paneth cell homeostasis, but also to Paneth- as well as
goblet-cell secretion.
Endoplasmic reticulum (ER) stress response-associated gene
variants, such as XBP1, are linked to IBD and to deﬁcient secre-
tory-cell responses. The ER insures proper synthesis, maturation
and folding of secreted proteins. Excessive protein synthesis, along
with insufﬁcient ER processing capacity, leads to accumulation of
unfolded proteins and ER stress. ER stress activates three signalling
pathways belonging to the unfolded-protein response (UPR), and
responsible for cellular recovery to the normal state. However, ge-
netic or environmental stresses disrupt these responses. UPR in-
cludes the IRE1/XBP1, ATF6 and PERK/eIF2a/ATF4 pathways. The
ER-associated IRE1/XBP1 degradation and protein-folding pathway
involves the activation of IRE1, a sequence-speciﬁc ribonuclease
required for splicing of the downstream transcription factor
XBP1. IEC-speciﬁc Xbp1 deletion results in increased ER stress –
leading to basal inﬂammatory increases and spontaneous small
intestinal inﬂammation, Paneth cell dysfunction, goblet cell reduc-
tion and increased sensitivity to experimental colitis [43]. Of note,
Xbp1 deletion enhances ER stress responses through increased
phosphorylation and activation of Ire1a, leading to the expansion
of intestinal stem cell pools. This suggests that defects in ER stress
responses and UPR may control IEC stem-cell growth and differen-
tiation in addition to IEC intrinsic inﬂammatory responses [44].
In addition to defects in Paneth cells, ER stress dysfunction may
lead to altered goblet cell phenotypes. Muc2missense mutations in
Winnie mice – created by random chemical mutagenesis – cause
spontaneous intestinal inﬂammation, with aberrant Muc2 biosyn-
thesis and accumulation, increased intestinal permeability,
enhanced colonic immune cell recruitment and cytokine produc-
tion, as well as ER stress responses. Thus, improper goblet-cell
mucin folding, which could result from genetic or environmental
modiﬁcations, may affect intestinal homeostatic responses [45].
Of interest, reduction of anti-inﬂammatory IL-10 signalling in
Winnie mice increases inﬂammation and colonic injury, in part
due to misfolded Muc2-protein accumulation in goblet cells and
increased ER stress. Thus, IL-10 may be an important promoter of
protein folding and an ER stress regulator in IEC, by insuring proper
mucin synthesis. The IL-10 pathway, which is associated withmultiple IBD gene variants, may be involved not only in im-
mune-cell regulatory responses but also in goblet cell-dependent
barrier function [46]. Other ER-stress genes, such as Ire1 and
Agr2, control intestinal homeostasis through secretory cells. While
Ire1a deﬁciency is lethal to the embryo, deletion of Ire1b – which is
selectively expressed in the digestive tract – results in ER accumu-
lation of aberrant Muc2 in goblet cells and enhanced ER stress.
Interestingly, both spliced Xbp1 and Muc2 mRNA levels are in-
creased. This suggests that Ire1b may act as a switch to adapt mu-
cin mRNA and protein synthesis to goblet cell needs as well as to
the capacity of goblet cells to process mucins [47]. Finally, deletion
of secretory cell-expressed Agr2 – an ER-associated protein disul-
ﬁde isomerase – leads to defects in Muc2 processing and synthesis,
accompanied by increased ER stress responses, altered Paneth and
goblet cells and spontaneous intestinal inﬂammation [48,49]. AGR2
gene variants may be associated with decreased AGR2 expression
in IBD patients [50]. Of interest is the additional role of ER stress
in IEC differentiation. Indeed, ER stress and UPR are induced when
stem cells become transit-amplifying cells during murine IEC dif-
ferentiation. This induction – through activation of the UPR Perk-
eIF2a pathway – leads to loss of stem-cell marker expression.
Notably, inhibition of Perk signalling through Perk silencing in
organoid cultures prevents IEC differentiation [51].
Recent data have conﬁrmed the intricate link between autoph-
agy and the ER stress response in intestinal homeostasis. CD
patients with a mutated ATG16L1 autophagy gene display in-
creased ER stress-marker production in Paneth cells, correlating
with enhanced mucosal association of invasive bacteria [52]. IEC-
speciﬁc deletion of Xbp1 in mice leads to ER stress, Paneth cell
dysfunction and spontaneous enteritis, as well as to increased
autophagic responses, notably in Paneth cells. Xbp1 deﬁciency
results in activation of the UPR phosphoPERK-phosphoEIF2a arm
which mediates autophagy induction. However, dual IEC-speciﬁc
Atg16l1 and Xbp1-mutant mice display loss of UPR-activated
autophagy associated with acute spontaneous ileitis and increased
inﬂammation, as opposed to single Xbp1-knockout mice – suggesting
once again the importance of autophagy to protect from inﬂamma-
tion in ER stress-inducing conditions. Thus, autophagy dampens ER
stress responses in IEC, but when disrupted induces inﬂammatory
responses [53]. Genetic or environmental-dependent changes may
result in perturbed interactions between autophagy and ER stress-
response pathways in IEC, disrupting protective responses and
unleashing ER stresses. Thus, these intrinsic IEC pathways are both
critical in sustaining intestinal homeostasis.
4. The aryl hydrocarbon receptor is an immunoregulatory
transmitter of diet- and bacteria-derived signals
The cytoplasmic aryl hydrocarbon receptor (AhR) moves to the
nucleus after ligand binding, to heterodimerize with the aryl
hydrocarbon receptor nuclear translocator (Arnt) [54,55]. AhR is
an environmental sensor, and its ligands include many xenobiotics
– such as dioxin – as well as endogenous ligands which have not all
been identiﬁed. Recent data have shown the important role of AhR
in intestinal homeostasis (Fig. 3). For example, IELs express high
levels of AhR. Indeed, IELs – which modulate barrier function
[24] – are regulated by AhR and are closely juxtaposed to IEC. IELs
play important roles in inducing epithelial repair and restricting
bacterial invasion. AhR-deﬁcient mice exhibit reduced numbers
of intestinal IELs through impaired survival, decreased IEC turn-
over, increased expression of the colonic AMP-gene Cryptdin and
increased bacterial load associated with changes in microbiota
composition, notably Bacteroides. Recent data show that AhR is in-
duced by a diet-derived ligand, namely the tryptophan-derived
phytochemical I3C found in cruciferous vegetables. Mice supple-
mented with a synthetic diet containing I3C show induced
Fig. 3. The aryl hydrocarbon receptor is an immunoregulatory transmitter of diet- and bacteria-derived signals. The aryl hydrocarbon receptor (AhR) is a ligand-dependent
transcriptional regulator forming a dimer with the aryl hydrocarbon receptor nuclear translocator (Arnt). AhR is induced by environmental signals such as dioxin, a
xenobiotic, as well as by diet-derived products such as derivatives of indole-3-carbinol found in cruciferous vegetables. AhR-mediated signals are critical to maintain
intraepithelial lymphocytes in the gut, thus insuring proper bacterial load control and mucosal immune cell function and healing. In addition, commensal bacteria, such as
Lactobacilli (LB), regulate group-3 innate lymphoid cell (ILC3s) functions by converting dietary tryptophan to the indole-3-aldehyde AhR ligand (IAld). AhR-dependent ILC3
activation leads to the production of IL-22, which modulates IEC barrier properties by inducing the expression of AMPs, such as Reg3g. This in turn, may hinder the expansion
of bacteria, such as segmented ﬁlamentous bacteria.
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levels. In contrast to AhR-deﬁcient mice, or mice supplemented with
low AhR ligand-diet, mice fed with AhR ligand-supplemented diets
are more resistant to DSS-induced colitis. Thus, AhR activation by
dietary components is critical to maintain IELs, and control
bacterial loads and intestinal inﬂammatory responses [56]. AhR-
dependent signalling may control the state of intestinal immune
activation.
Another recently-discovered target of AhR action is the innate
lymphoid cell (ILC). The three major ILC groups differentiate inde-
pendently of an antigen-dependent response, but their develop-
ment relies on speciﬁc transcription factors involved in Th
adaptive cell differentiation, namely T-bet, GATA3 and RoRct
[57,58]. ILCs populate the gut mucosal lining and respond to bacte-
rial components through Toll-like receptor signalling. ILC re-
sponses are regulated indirectly through bacteria-dependent
modulation of myeloid cell or IEC cytokine expression. Group-3
RoRct-expressing ILCs inﬂuence intestinal epithelial barrier func-
tion through the production of IL-22, which induces the expression
of IEC AMPs – such as Reg3 g – and mucins [59]. In addition, ILCs
prevent bacterial spreading, as shown by breach of commensal
bacteria containment – notably Alcaligenes species – and systemic
inﬂammation, in ILC-depleted mice [59]. Recent data have shown
that AhR is critical for ILC modulation and that bacterial metabolic
by-products inﬂuence ILCs through group-3 RoRct-expressing ILCs.
Indeed, AhR-deﬁcient mice display decreased numbers of group-3
RoRct-expressing ILCs through induced apoptosis, and lower IL-22
levels. While AhR-deleted mice are more sensitive to Citrobacter
rodentium infection, IL-22 administration reduces mortality rates
[60]. In addition, AhR-deﬁcient mice show increased numbers of
small-intestine Th17 cells associated with expansion of segmentedﬁlamentous bacteria (SFB), which promote Th17-cell activation.
Deletion of one Rorc allele in an AhR-deﬁcient mouse background
further reduces RoRct-expressing ILC numbers – resulting in spon-
taneous colitis – correlating with increased SFB and Th17 cells [61].
Of note, dietary tryptophan-dependent expansion of select Lacto-
bacilli species in mice leads to increased production of tryptophan
metabolites, such as indole-3-aldehyde – an AhR ligand – and in-
creased IL-22 production. As opposed to AhR-deﬁcient mice,
administration of indole-3-aldehyde to wild-type mice protects
from mucosal Candida albicans infection or DSS-induced inﬂamma-
tion [62]. Thus, the Ah receptor is a sensor and transmitter of exog-
enous dietary and bacterially-derived signals in the gut.
5. Microbiota and bacterial metabolites shape the anti-
inﬂammatory and immunosuppressive mucosal environment
Genome-wide association studies and murine experimental
models support the critical role of the adaptive immune Th17/T-
reg cell axis in regulating and maintaining intestinal homeostasis
[26,27]. IL-17 and IL-22 cytokine-producing Th17 cells act on in-
nate immune cells and IECs. Th17 cells regulate neutrophil recruit-
ment, AMP production and barrier function, among others, and
play protective as well as inﬂammatory roles [63]. Small-intestine
mucosal Th17 cells depend on the presence of microbiota for their
accumulation. Indeed, GF mice re-acquire Th17 cells after bacterial
re-implantation [64]. T-reg cells expressing the Foxp3 transcrip-
tion factor are critical to establishing immunological tolerance to
self-antigen and to harnessing disproportionate immune re-
sponses, by regulating speciﬁc T cell lineages, among others. The
gut contains high numbers of Foxp3-expressing T-reg cells – which
control mucosal homeostasis through anti-inﬂammatory IL-10 [65]
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ciﬁc IL-10 deﬁciency in mice leads to spontaneous colitis, showing
the importance of T-reg cell-derived IL-10 in regulating colonic im-
mune responses [67,68]. Recent data suggests that most colonic T-
reg cells involved in maintaining commensal antigen tolerance
actually derive from the thymus instead of its periphery [69].
Germ-free (GF) mice, bred in a bacteria-free environment, have
enabled functional studies of the role of distinct microbiota ele-
ments in intestinal homeostasis [70]. Bacterial re-implantation
experiments have shown the importance of speciﬁc bacterial spe-
cies in shaping and instructing mucosal immune responses, by
both innate and adaptive homeostatic mechanisms. For example,
segmented ﬁlamentous bacteria (SFB) mostly colonize the intesti-
nal ileum by adhering directly to IECs. In addition to increasing
IEL numbers, SFB colonization of GF mice induces Th17 cell differ-
entiation, leading to increased expression of inﬂammatory and
AMP genes – and enhanced protection against Citrobacter
rodentium infection [71]. One important downstream effector of
SFB-mediated signalling is Serum amyloid A (Saa) – an acute phase-
protein gene whose expression is induced after SFB colonization –
and which may stimulate Th17 cell differentiation through lamina
propria dendritic cell activation (Fig. 4) [71,72].
The mature intestinal mucosal system is composed of well-
developed lymphoid follicles and Peyer’s patches, which are both
sites of B-cell immunoglobulin A (IgA) production in the gut [73].Fig. 4. Microbiota and bacterial metabolites shape the anti-inﬂammatory and immunosu
responses through different mechanisms. Segmented ﬁlamentous bacteria (SFB) epithelia
inducing Serum amyloid A (SAA). Bacteroides fragilis, through the action of the imm
regulatory (T-reg) cell expansion and activation. Clostridium species also induce Foxp3
expression of T-reg cell modulators TGF-b and IDO. Fermentation of diet ﬁbers by bacter
as signals modulating T-reg cell activation. Short-chain fatty acids (SCFAs), such as propi
deacetylase (HDAC) 6 and 9 inhibition, lead to increased Foxp3 acetylation, stability and
Regulation of HDAC activity is important, as pharmacologic HDAC inhibitors increase T-re
recent data show that HDAC may play important roles in regulating IEC-associated inteMucosal secretory IgAs play multiple protective roles by, among
others, restricting bacterial entry and antigen access to the mucosa,
through immune exclusion [74]. The microbiota plays an impor-
tant role in the maturation of gut-associated lymphoid tissues. In-
deed, GF or antibiotic-treated mice display an immature intestinal
mucosal immune system, with decreased B-cell IgA levels. Micro-
biota-dependent induction of IgA-producing B cells involves the
activation of innate Myd88-regulated signalling in mucosal follicu-
lar DCs – in response to which DCs secrete B-cell class-switching
and IgA-inducing factors such as TGF-b [75]. Restoration of SFB
in GF mice induces low levels of IgA synthesis, suggesting that spe-
ciﬁc bacterial species or combinations of bacterial communities are
needed to achieve mature IgA responses [76]. As bacteria play
important roles in gut B cell maturation and IgA induction, IgAs
are critical for establishing appropriate gut microbiota. Indeed,
microbiota is altered both in quantity and in quality, in Ig class-
switching recombination-defective mice with reduced IgA levels
[77].
As well, speciﬁc microbial species are critical for the establish-
ment and activation of T-reg cell populations in the gut. In contrast
to the small intestine, Foxp3-expressing T-reg cell numbers in the
colon are reduced in GF and in antibiotic-treated mice [78].
However, colonization with pathogen-free murine feces – or with
a selected number of Clostridia strains – induces colonic Foxp3-
expressing T-reg cell accumulation (Fig. 4) [78]. This is associatedppressive mucosal environment. Speciﬁc bacterial species instruct mucosal immune
l adhesion increases IEL numbers and enhances Th17 cell differentiation, in part by
unomodulatory component polysaccharide A (PSA), induces Foxp3-expressing T-
-expressing T-reg cell accumulation and activation through increased IEC-speciﬁc
ia, such as Clostridium species, produces critical bacterial-derived metabolites acting
onate and butyrate, either through Ffar2 receptor signalling and/or through histone
expression, resulting in the promotion of T-reg cell immune-suppressive activities.
g cell production and activity and protect from DSS-induced colitis in mice. Of note,
stinal homeostatic responses.
C. Asselin, F.-P. Gendron / FEBS Letters 588 (2014) 4148–4157 4155with increased IEC-speciﬁc expression of TGF-b as well as indole-
amine 2,3-dioxygenase (IDO), two important regulators of T-reg
cell development [79,80], and with augmented T-reg cell-mediated
expression of the immunosuppressive cytokine IL-10. These Clos-
tridia-mediated effects are independent of Toll-like receptor signal-
ling, as shown by the normal T-reg cell numbers in colonized mice
deﬁcient in Myd88. Increased Clostridium load in mice suppresses
colitis symptoms in chemically-induced models of colitis [78].
Thus, these data show that speciﬁc Clostridia bacterial subsets in-
crease T-reg cell numbers and activity, in part through the induc-
tion of increased IEC signalling. The same research group has
shown that, when reimplanted in GF mice, 17 selected human-de-
rived Clostridia strains induce T-reg cell expansion, accompanied
by IL-10 anti-inﬂammatory gene expression increases. Oral admin-
istration of Clostridia bacterial strains again reduces colitis symp-
toms in experimental colitis models [81]. In addition to Clostridia,
other commensal bacteria play positive roles on T-reg develop-
ment in the gut, with different mechanisms. Bacteroides fragilis
re-implantation in GF mice increases Foxp3-expressing T-reg cell
immunosuppressive activity, as shown by increased IL-10 produc-
tion as well as mucosal tolerance, through the action of the bacte-
rial immunomodulatory component Polysaccharide A (PSA). PSA
directly induces Foxp3-expressing T-reg cell differentiation and
anti-inﬂammatory activity through TLR2-dependent mechanisms,
and reduces 2,4,6-trinitrobenzenesulfonic acid-mediated colitis
symptoms [82]. Intestinal colonization with diverse bacterial spe-
cies, namely altered Schaedler ﬂora (ASF) [83] – in contrast to Clos-
tridia colonization – leads to TLR-dependent expansion and
activation of T-reg cells, as determined by disrupted T-reg cell acti-
vation in colonized mice without the TLR adaptor molecule Myd88
[84]. Again, T-reg cell activation requires IL-10 production. ASF-
dependent T-reg cell expansion is necessary to maintain intestinal
homeostasis after mucosal injury with low doses of DSS [84]. In
conclusion, unique bacterial species or combinations of selected
bacteria regulate T-reg cell homeostasis in the gut.
Recently, by-products of ﬁber fermentation – namely the short-
chain fatty acids acetate, propionate and butyrate (SCFA) – have
been identiﬁed as critical signals modulating T-reg cell activation.
While GF mice display decreased SCFA concentrations as opposed
to GF bacteria-reconstituted mice, increasing SCFAs in GF mice ele-
vates colonic Foxp3-expressing and IL-10-secreting T-reg cells,
without altering Th1/Th17 cell frequency. The same is observed
when SCFAs are increased in speciﬁc pathogen-free mice [85].
Colonic T-reg cells express higher levels of the SCFA-dependent
G-protein coupled receptor GPR43 (Ffar2), as opposed to spleenic
T-reg cells. In contrast to Ffar2-deﬁcient mice, wild-type mice trea-
ted with propionate show increased Foxp3- and IL-10-expressing
colonic T-reg cells and enhanced T-reg cell-speciﬁc histone acety-
lation, correlating with decreased histone deacetylase Hdac6 and
Hdac9 mRNA levels [85]. The exact role of SCFA-dependent Ffar2
signalling and the cell types involved still remain to be determined.
Indeed, different phenotypes of decreased [86,87] or increased
[88,89] sensitivity to experimental colitis have been observed in
Ffar2-knockout mice. SCFAs inhibit HDAC activity and modulate
immunity [90]. HDAC inhibition in mice with pharmacological
inhibitors – such as Trichostatin A – increases Foxp3 acetylation,
stability and DNA-binding activity, as well as enhances T-reg cell
production and activity, resulting in decreased experimental DSS-
induced colitis symptoms [91]. Foxp3-expressing T-reg cells dis-
play augmented suppressive activity in mice deﬁcient in Hdac6
or Hdac9 [92–95]. Another SCFA, butyrate – as opposed to acetate
– regulates T-reg cell differentiation. Indeed, mice fed with a
butyrylated high-amylose starch diet display increased colonic
Foxp3-expressing and IL-10-producing T-reg cells [96]. This effect
does not require TLR signalling in response to butyrylated starch
diets – as Myd88-deﬁcient mice show similar induction of colonicT-reg cells compared to wild-type. Increased histone H3 acetyla-
tion at Foxp3 regulatory sequences correlates with increased
Foxp3 expression [96]. In another study, butyrate was shown to in-
duce colonic T-reg cell differentiation when administered through
enemas or feeding with butyrylated starch, but not by administra-
tion in drinking water [97]. In addition, the HDAC inhibitory effect
of butyrate is critical to enhance dendritic cell potential to promote
T-reg cell differentiation, as assessed by increased Foxp3 expres-
sion. These data suggest that SCFAs may play different and comple-
mentary roles in colonic T-reg cell differentiation – and that HDACs
act both as critical sensors of the complex intestinal milieu and as
important transmitters of the intricate environmental signals reg-
ulating intestinal mucosal homeostasis.
In addition to SCFAs, other gut metabolites may play important
roles in intestinal homeostasis, such as hydrogen sulﬁde (H2S). H2S
is a gaseous signalling molecule that is produced endogenously
from cysteine by cystathionine c-lyase and b-synthase in the mu-
cosa [98], but also exogenously by ubiquitous sulphate-reducing
bacteria (SRB) [99]. GF mice display decreased amounts of free
H2S in the gut, along with reduced tissue cysteine levels and
H2S-synthesizing enzymatic activities [100]. Interestingly, recent
data from a GF mouse model reconstituted with a combination
of human gut bacterial species – with or without the SRB Desulf-
ovibrio piger – have uncovered a role for SRB and high H2S levels
in establishing diet-speciﬁc metabolic responses in gut bacterial
communities as well as in host cells [101]. While both pro- or
anti-inﬂammatory gut responses have been attributed to H2S, the
latest studies support a key anti-inﬂammatory role for both endog-
enous and exogenous sources of H2S in regulating leukocyte migra-
tion, tissue repair and inﬂammatory responses – and thereby
maintaining intestinal mucosal homeostasis [102]. Thus, numerous
bacterial metabolites, and variations in their levels as a result of al-
tered environmental conditions, may well be critical for intestinal
homeostasis.
6. Class I HDACs are critical regulators of IEC-mediated
regulation of intestinal homeostasis
Microbiota and bacterial by-products may regulate intestinal
homeostasis in part by controlling the formation of the acetylome,
not only in T-reg cells but also in IECs. Acetylation is an epigenetic
modiﬁcation at the interface of the environment, diet and microbi-
ota as well. Recent data have shown that murine microbiota re-
implantation in germ-free mice fed with 15N-labeled diet increases
the level of acetylated proteins in the liver and colon. Acetylated
proteins are related to metabolism and energy control, suggesting
the importance of the microbiota in establishing acetylation pat-
terns, as well as intestinal mucosal metabolic pathways [103].
The SCFA butyrate is an important IEC energy source and provides
a high level of energy intake. Colonocytes from GF mice display de-
creased energy levels, correlating with decreased mitochondrial
TCA cycle enzyme expression, diminished ATP levels, AMPK activa-
tion and autophagy. However, restoration of butyrate levels – by
colonizing GF mice with butyrate-producing bacteria – restores
mitochondrial energy homeostasis and oxidative metabolism, as
well as prevents autophagy [104]. Thus, butyrate and bacterial
by-products directly affect IEC energy metabolism. In addition to
T-reg cells, recent evidence has shown that IEC-dependent homeo-
stasis also depends on HDAC activities. Indeed, IEC-speciﬁc dele-
tion of both class I Hdac1 and Hdac2 disrupts intestinal tissue
architecture, reduces goblet and Paneth cell numbers, increases
IEC proliferation, migration and permeability, and leads to chronic
inﬂammation, while inducing novel homeostatic anti-inﬂamma-
tory signals [105]. Dual Hdac1/Hdac2 IEC-speciﬁc mutant mice
show increased sensitivity to experimental DSS-induced colitis.
While IEC-deﬁcient Hdac2 deletion does not affect intestinal
4156 C. Asselin, F.-P. Gendron / FEBS Letters 588 (2014) 4148–4157architecture, mutant mice are more resistant to experimental coli-
tis, suggesting that HDAC activity dosage may exquisitely control
intestinal homeostasis [106]. Of note, IEC-speciﬁc deletion of
Hdac3 results in increased IEC proliferation, Paneth cell loss, de-
creased AMP gene expression, impaired microbiota content, and
increased sensitivity to experimental DSS-induced colitis [107].
Thus, HDACs may well act as epigenetic regulators of environmen-
tal-dependent IEC homeostatic and inﬂammatory responses by
shuttling intricate environmental cues.
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